U.S. flag

An official website of the United States government

GTR Home > Tests > Congenital heart disease Deletion / Duplication panel

Indication

This is a clinical test intended for Help: Diagnosis, Mutation Confirmation

Clinical summary

Help

Imported from OMIM

Atrial fibrillation is the most common sustained cardiac rhythm disturbance, affecting more than 2 million Americans, with an overall prevalence of 0.89%. The prevalence increases rapidly with age, to 2.3% between the ages of 40 and 60 years, and to 5.9% over the age of 65. The most dreaded complication is thromboembolic stroke (Brugada et al., 1997). For a discussion of genetic heterogeneity of familial atrial fibrillation, see ATFB1 (608583).

Clinical features

Help

Imported from Human Phenotype Ontology (HPO)

  • Paroxysmal atrial fibrillation

Conditions tested

Target population

Help

Individuals whose clinical findings are consistent with the specific disorder.

Citations

Not provided

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.